CPRX vs MCK · P/E 18, rev $491.7M vs P/E 20, rev $403.43B
Catalyst Pharmaceuticals Inc (CPRX) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the CPRX and MCK stock pages for the full models.
Not investment advice.